ArticleNagoya journal of medical science2025
Successful treatment with sintilimab plus anlotinib for SMARCA4-deficient non-small cell lung cancer withMET exon 14 skipping: a case report.
Hongfei Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.